1. Alessia Biolchi
SUMMARY OF QUALIFICATIONS
 Native Italian, conversational English
 Computer skills: Microsoft Office (Word, Excel,Power Point), Graphpad, internet
 Qualified in the manipulation of highly pathogenic bacteria and the organization of activity in BSL3
laboratories according to WHO, CDC and ISS guidelines.
 Familiar with GCP and GMP practices
 Effective leader and team player, fast learning
 Good interpersonal, communication, and presentation abilities
 Excellent organizational skills and solving capabilities
EDUCATION
1995.2000 Biology Degree, University of Bologna – Italy
1990-1995 “Diploma di maturita’ scientifica” – Liceo Scientifico “M.Montessori”, Porretta T. (BO)- Italy
PROFESSIONAL EXPERIENCE
May 2002 – present Chiron Corp/Novartis V&D/GSK vaccine (Research Center) Siena, ITALY
SCIENTIST I Research – Vaccines Emeryville, CA, USA
Marburg, GERMANY
“MenB project”
 Project liason for MenB vaccine: represents the serology unit in the team and in the project,
analyze and report serological experimental data to Senior Management,participate to relevant
meeting and assist management in the preparation of answers to questions from authorities related
to immunoassay performance.
 Support clinical serology department in phaseII/phaseIII trial related activity and perform
immunoassays (hSBA analysis) on human sera from clinical trial.
 Ensure that the experimental documentation comply with the Regulatory and Patent
Departments requirements (write development protocols, reports, SOPs, validation documents and
history files related to immunoassays)
 Support test development, validation, transfer and implementation of new technologies, intended to
improve assay performances.
 Manage and organize activity for collection and selection of complement for immunoassays
 Serve as recognized expert in the set-up, maintenance and implementation of a Database for
the collection and quality check of serological data
 Supervise and perform activity to collect and catalogue human and animal samples in
compliance with procedure in place.
 Perform immunoassays (SBA, ELISA, FACS, competitive SBA) to select antigen candidates,
adjuvants, formulation and immunization schedule to improve MenB vaccine and to determine
immunogenicity and stability of clinical lots
 Perform binding assays to determine the adhesion level of different Neisseria strains to
endothelial cells and cytotoxicity assays to determine the damage caused by Neisseria strains
to endothelial cells.
Aug 2001- Dec 2001 ATO (Agrotechnological Research Institute) Wageningen, THE NETHERLAND
JUNIOR SCIENTIST Research – microbiology and molecular biology
“Over expression and characterization of ∆12 desaturase gene in Cryptococcus
curvatus”
 Culture growth and microbiological analysis of yeast and bacteria.
 Preparation of plasmids (digestion, ligation, purification), genetic transformation of E. coli and
yeast, Northern and Southern analysis

2. 1999-2001 University of Bologna (Cytology and Histology Unit) Bologna, ITALY
JUNIOR SCIENTIST Research – Genome analysis
“Expression profile of epidermal differentiation complex genes in normal and anal cancer
cells”
 RT-PCR, electrophoresis, RNA and DNA extraction and purification, Northern blot and macro
array analysis.
 Bioinformatics analysis: sequence retrieval and alignment, PCR primer design
PROFESSIONAL DEVELOPMENT:
10-11 Seotember 2015 GSK course: Siena
• “COMUNICAZIONE INTERPERSONALE”
19-20 May 2014 Novartis course: Siena
• “COMUNICAZIONE INTERPERSONALE”
14-15 October 2012 Novartis course: Siena
• “POWERFUL PRESENTATION”
15-17 December 2011 Project management Lab (PM): Siena
• “PROJECT MANAGEMENT COURSE”
17-18 November 2010 Pharmaceutical Training international (PTI): London (UK)
• “INTRODUCTION TO IMMUNOGENICITY”
11-12 November 2010 SAS Institute (@Novartis): Siena
• “Course on JMP Software”
6-16 September 2010 Novartis course:
• “Applied Statistics and Design of Experiments” Siena
2007- 2015 Novartis Integrity & Compliance e-learning program: e-learning
• Quality Performance Management
• Health, Safety & Environment in the Workplace
• Misconduct Reporting Requirements– Business Practices Office (BPO)
• Code of Conduct & Corporate Citizenship
• Financial Integrity
• Global information security
• Responsible recordkeeping
• Professional Practices Policies (P3s) - Ethical Business Practices
• Adverse Events Key Points e-Training
LIST OF PUBLICATIONS: http://www.ncbi.nlm.nih.gov/pubmed/?term=Biolchi+Alessia
REFERENCES provided on request.